Interferon alpha-2a biosimilar - BiosidusAlternative Names: Biosidus interferon alpha 2a; Inferon; Inmutag; Inter 2A
Latest Information Update: 20 Sep 2013
Price : *
At a glance
- Originator Biosidus S.A.
- Class Antineoplastics; Antivirals; Interferons
- Mechanism of Action Interferon alfa 2a stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Cancer; Hepatitis B; Hepatitis C; Kaposi's sarcoma
Most Recent Events
- 17 Apr 2016 Biomarkers information updated
- 15 Nov 2011 Launched for Cancer in Argentina (Parenteral)
- 15 Nov 2011 Launched for Cancer in Russia (Parenteral)